Rallybio Corporation
General ticker "RLYB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.9M (TTM average)
Rallybio Corporation follows the US Stock Market performance with the rate: 41.5%.
Estimated limits based on current volatility of 2.7%: low 8.81$, high 9.30$
Factors to consider:
- Earnings expected soon, date: 2026-05-12 bmo
- Total employees count: 25 (-41.9%) as of 2024
- Top business risk factors: Product development delays, Regulatory and compliance, Market acceptance, Limited operating history, Sales and marketing challenges
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.99$, 10.11$]
- 2026-12-31 to 2027-12-31 estimated range: [3.25$, 8.45$]
Short-term RLYB quotes
Long-term RLYB plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.86MM |
| Operating Expenses | $28.92MM |
| Operating Income | $-28.06MM |
| Non-Operating Income | $19.09MM |
| R&D Expense | $19.60MM |
| Income(Loss) | $-8.98MM |
| Profit(Loss)* | $-8.98MM |
| Stockholders Equity | $57.96MM |
| Assets | $62.26MM |
| Operating Cash Flow | $-29.81MM |
| Investing Cash Flow | $47.27MM |
| Financing Cash Flow | $0.02MM |
| Earnings Per Share** | $-1.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.